Literature DB >> 3511694

Effects of prazosin, atenolol, and thiazide diuretic on plasma lipids in patients with essential hypertension.

A J Neusy, J Lowenstein.   

Abstract

The effects of prazosin and atenolol monotherapy on plasma lipid concentrations were compared in 51 patients with mild to moderate essential hypertension. Prazosin monotherapy (mean dose 5.4 +/- 5.3 mg per day) resulted in a significant decrease in total and low-density lipoprotein cholesterol concentrations; these changes were evident at three months and at six to 12 months. Atenolol monotherapy (mean dose 66 +/- 23 mg per day) resulted in a significant increase in plasma triglyceride concentration that persisted during one year of treatment. The deletion of thiazide from the regimen of prazosin plus thiazide resulted in a small stepwise decrease in plasma triglyceride concentration over 12 months of observation. The addition of polythiazide (0.5 mg two to three times weekly) to the regimen of patients in whom acceptable blood pressure was not attained with prazosin or atenolol monotherapy resulted in a decrease in blood pressure, averaging 18.8 mm Hg for systolic and 10.3 mm Hg for diastolic, and a small, though significant, increase in the concentration of low-density lipoprotein cholesterol. It is suggested that the effects of prazosin on plasma lipid composition may be mediated, at least in part, by blocking an action of either the sympathetic nervous system or circulating catecholamines that normally modulate lipoprotein metabolism and might mediate the lipid alterations induced by thiazide diuretics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511694     DOI: 10.1016/0002-9343(86)90166-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse.

Authors:  Janice C Froehlich; Brett Hausauer; Stephen Fischer; Bradley Wise; Dennis D Rasmussen
Journal:  Alcohol Clin Exp Res       Date:  2015-08       Impact factor: 3.455

3.  Drug treatment in hypertension--metabolic side effects of drugs.

Authors:  P Little; A Trafford; G Girling; A Hasler; A Craven
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Disturbances of insulin in British Asian and white men surviving myocardial infarction.

Authors:  L O Hughes; J K Cruickshank; J Wright; E B Raftery
Journal:  BMJ       Date:  1989-08-26

5.  A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.

Authors:  U Hauf-Zachariou; L Widmann; B Zülsdorf; M Hennig; P D Lang
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Angiographic comparison of coronary artery disease between Asians and Caucasians.

Authors:  J Dhawan; C L Bray
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

7.  Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.

Authors:  A Lehtonen
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

8.  The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.

Authors:  R Fogari; A Zoppi; F Tettamanti; G Malamani; C Pasotti
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.